Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Seimetz, N. Parajuli, R. Schermuly, A. Ghofrani, W. Seeger, F. Grimminger, N. Weissmann (Giessen, Germany). Tobacco smoke-induced emphysema and pulmonary hypertension – Role of NADPH oxidase NOX2. Eur Respir J 2010; 36: Suppl. 54, 2193

Member's Comments

No comment yet.

Related content which might interest you: Role of IL-1α and IL-1β in cigarette smoke-induced pulmonary inflammation and COPD Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011 Localisation of NADPH oxidases and their role in hypoxia induced pulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 804s Year: 2006 Inhibition of NOX2 oxidase activity ameliorates cigarette smoke-induced lung inflammation and wasting in mice Source: International Congress 2016 – Novel insights into the treatment of COPD Year: 2016 Role of lysyl oxidases in pathogenesis of pulmonary emphysema Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia Year: 2017 Increased xanthine oxidase activity in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2009; 34: 276 Year: 2009 Targeting of mitochondrial superoxide in chronic hypoxia-induced pulmonary hypertension Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 Phosphodiesterase inhibitors as promising therapies for cigarette smoke-induced emphysema and pulmonary hypertension (PH) in mice Source: International Congress 2014 – Pulmonary hypertension: improving treatment in PAH Year: 2014 Activation of membrane nadph oxidase in idiopathic pulmonary fibrosis (IPF) fibroblasts Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair Year: 2007 Viral mimetic Poly(I:C) exacerbates cigarette smoke-induced pulmonary inflammation by facilitating the release of neutrophil-derived elastase Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014 Role of activin-A in cigarette smoke-induced inflammation and COPD Source: Eur Respir J 2014; 43: 1028-1041 Year: 2014 The effect of bosentan in occlusive pulmonary hypertension in rats – Role of oxidative and nitrative stress attenuation Source: Annual Congress 2010 - Pulmonary vascular diseases Year: 2010 Role of IFNg in smoke-induced pulmonary emphysema and cachexia Source: Eur Respir J 2005; 26: Suppl. 49, 732s Year: 2005 Lung remodeling in cigarette smoke-induced emphysema is independent of nitric oxide participation Source: Annual Congress 2010 - Proteases and the matrix Year: 2010 Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways Source: Eur Respir J 2003; 22: 457-461 Year: 2003 Role of CD69 in the pathogenesis of elastase-induced pulmonary inflammation and emphysema Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 Hypoxia-dependent regulation of non-phagocytic NADPH oxidase NOX4 in the pulmonary vasculature Source: Eur Respir J 2007; 30: Suppl. 51, 56s Year: 2007 The effect of Monoamine oxidase A inhibition on experimentally induced pulmonary arterial hypertension Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018 Targeting NADPH oxidase-2 reduces cigarette smoke-induced lung inflammation and skeletal muscle wasting in mice Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018 Role of IL-1? and the Nlrp3/caspase-1/IL-1? axis in cigarette smoke-induced pulmonary inflammation and COPD Source: Eur Respir J 2011; 38: 1019-1028 Year: 2011 Decreased heme oxygenase (HO) - 1 in induced sputum of smokers with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 84s Year: 2003